Elevar Therapeutics

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. The company, founded in 2019, is rooted in oncology and applies the same rigor and diligence to identifying and developing promising medicines for complex yet under-treated health conditions across a range of therapeutic areas. Elevar Therapeutics develops and assesses therapeutics based upon their ability to make a meaningful impact for patients and their treatment experiences. They invest in proven and promising therapeutics at various stages of development and advance them through clinical and regulatory processes with the goal of commercialising improved treatment options for patients and the healthcare providers who treat them.

Services include:
- Contract Development and Manufacturing Organisation (CDMO)
- Clinical Supply Manufacturing
- Commercial Manufacturing
- Analytical Development
- Formulation Development
- Packaging Services

Elevar Therapeutics is committed to engaging with the highest ethical standards, driven by a passion to address the underserved needs of patients, caregivers, and healthcare providers. For more information, please visit elevartherapeutics.com.